TARO - Taro Pharmaceutical EPS beats by $0.22 misses on revenue February, 03 2020 05:25 PM Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical (NYSE:TARO): Q3 GAAP EPS of $1.76 beats by $0.22.More news on: Taro Pharmaceutical Industries Ltd., Earnings news and commentary, Healthcare stocks news, Read more ...